These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4566432)

  • 21. Preclinical testing of iopromide. 2nd communication: toxicological evaluation.
    Krause W; Schöbel C; Press WR
    Arzneimittelforschung; 1994 Nov; 44(11):1275-9. PubMed ID: 7848345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The kidney and ascorbic acid].
    Arvy L
    Laval Med; 1970 Jan; 41(1):68-85. PubMed ID: 5515130
    [No Abstract]   [Full Text] [Related]  

  • 23. Endogenous ascorbic acid synthesis and recommended dietary allowances for vitamin C.
    Ginter E
    Am J Clin Nutr; 1981 Jul; 34(7):1448-51. PubMed ID: 7258136
    [No Abstract]   [Full Text] [Related]  

  • 24. [Biochemical bases for the treatment of Parkinson's syndrome with L-dopa].
    Pletscher A; Bartholini G; Gey KF; Jenni A
    Schweiz Med Wochenschr; 1970 May; 100(19):797-804. PubMed ID: 4924275
    [No Abstract]   [Full Text] [Related]  

  • 25. [Establishment of the maximum permissible concentration of ethyl acetate in reservoir water].
    Saratikov AS; Trofimovich EM; Burova AB; Zamoshchina TA; Melomed FI
    Gig Sanit; 1983 Apr; (4):66-7. PubMed ID: 6862210
    [No Abstract]   [Full Text] [Related]  

  • 26. General pharmacology of a Pseudomonas vaccine prepared from outer-membrane fractions of Pseudomonas aeruginosa.
    Park WJ; Kim YH; Jeong SM; Park KH; Kim HS; Kim YS; Hahm KS; Munt PL; Algate DR
    Arzneimittelforschung; 1996 Oct; 46(10):1001-6. PubMed ID: 8931896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Methods of evaluating the ascorbic acid adequacy of the human body].
    Bondarev GI
    Gig Sanit; 1974 Feb; (2):82-5. PubMed ID: 4611836
    [No Abstract]   [Full Text] [Related]  

  • 28. [General toxic and organotropic side-effects of cephalothin in acute and chronic experiments].
    Berezhinskaia VV; Solov'ev VN; Berezina EK; Dolgova GV; Kovalenko LP
    Antibiotiki; 1981 Jan; 26(1):44-50. PubMed ID: 7212682
    [No Abstract]   [Full Text] [Related]  

  • 29. Toxicological evaluation of pidotimod.
    Coppi G; Amico-Roxas M; Bertè F; Bussi R; Gnemi P; Harling RJ; Mailland F; Manzardo S; Massey JE; Spencer-Briggs DJ
    Arzneimittelforschung; 1994 Dec; 44(12A):1448-53. PubMed ID: 7857340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. General pharmacological profile of the new anti-ulcer drug 3-[[[2-(3,4-dimethoxyphenyl)ethyl]carbamoyl]methyl]-amino-N -methylbenzamide.
    Hirohashi M; Takasuna K; Kasai Y; Usui C; Tamura K; Kojima H
    Arzneimittelforschung; 1993 May; 43(5):569-77. PubMed ID: 8329002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on the distribution of (1-14C) ascorbic acid and (1-14C) dehydroascorbic acid in guinea pigs after oral application.
    Hornig D; Weber F; Wiss O
    Int J Vitam Nutr Res; 1974; 44(2):217-29. PubMed ID: 4854482
    [No Abstract]   [Full Text] [Related]  

  • 32. General pharmacology of recombinant human basic fibroblast growth factor.
    Okumura M; Yajima M; Nishimura T; Ikeda H; Nishimori T
    Arzneimittelforschung; 1996 Jul; 46(7):727-39. PubMed ID: 8842346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. General pharmacological properties of the human corticotropin-releasing hormone corticorelin (human).
    Andoh K; Kimura T; Saeki I; Tabata R; Yamazaki S; Eguchi I; Hanazuka M; Horii D; Munt PL; Davis AS
    Arzneimittelforschung; 1994 Jun; 44(6):715-26. PubMed ID: 8053970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New approach to establishing a correlation between radiation resistance and metabolic processes in mammals of different species].
    Tiazhelova VG
    Radiobiologiia; 1981; 21(3):444-6. PubMed ID: 7291500
    [No Abstract]   [Full Text] [Related]  

  • 35. Teratogenic drug screening. Present procedures and requirements.
    Tuchmann-Duplessis H
    Teratology; 1972 Jun; 5(3):271-85. PubMed ID: 5067718
    [No Abstract]   [Full Text] [Related]  

  • 36. General pharmacological properties of UFT, a new type of anti-cancer agent consisting of 1-(2-tetrahydrofuryl)-5-fluorouracil (FT) and uracil. I: Pharmacological analysis of the combined effect of FT and uracil.
    Yamamoto J; Toide K; Haruno A; Yoshimura Y; Unemi N
    Arzneimittelforschung; 1981; 31(8):1268-78. PubMed ID: 6794578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Electrophysiological characteristics of the smooth muscles of the gastrointestinal tract].
    Kaplunenko NA; Shevchuk PN
    Usp Fiziol Nauk; 1984; 15(4):68-84. PubMed ID: 6438937
    [No Abstract]   [Full Text] [Related]  

  • 38. General pharmacological profile of the novel cholecystokinin-A antagonist loxiglumide.
    Saito T; Ukai K; Masuda T; Nakagawa T; Kimura K; Fujii M; Wakatsuki K; Saeki M; Kasai H
    Arzneimittelforschung; 1997 Dec; 47(12):1375-82. PubMed ID: 9450167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological studies on timiperone, a new neuroleptic drug Part II: General pharmacological properties.
    Yamasaki T; Kojima H; Tanaka M; Aibara S; Hirohashi M; Kasai Y; Tsubokawa M; Watanabe K; Akashi A
    Arzneimittelforschung; 1981; 31(4):707-15. PubMed ID: 6113834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hygienic evaluation of the residues of the fungicide Carpene (dodecylguanidine acetate) in apples].
    Tovstenko AI
    Vopr Pitan; 1973; 32(5):72-4. PubMed ID: 4793430
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.